AC
CELZ icon

Armistice Capital’s Creative Medical Technology CELZ Stock Holding History

Armistice Capital’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.9K Buy
+42,000
New +$90.7K ﹤0.01% 317
2025
Q2 		– Sell
-148,000
Closed -$321K – 215
2025
Q1 		$321K Buy
+148,000
New +$516K ﹤0.01% 189
2022
Q3 		– Sell
-124,418
Closed -$933K – 206
2022
Q2 		$933K Buy
+124,418
New +$2.01M 0.02% 128

Other funds holding CELZ

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Armistice Capital's CELZ Position: Q2 2026 in Review

Armistice Capital opened a new position in Creative Medical Technology (CELZ) in Q2 2026: 42,000 shares worth $60.9K. The stake represents ﹤0.01% of the portfolio and ranks #317 among its holdings. This is a return to the name: Armistice Capital previously reported a position in CELZ as recently as Q1 2025.

Armistice Capital first reported a position in CELZ in Q2 2022 and has held it in 3 quarters since. The position peaked at $933K in Q2 2022. 15 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • Armistice Capital held 42,000 shares of Creative Medical Technology worth $60.9K as of Q2 2026.
  • Creative Medical Technology was a new Armistice Capital position in Q2 2026.
  • Creative Medical Technology made up ﹤0.01% of Armistice Capital's portfolio in Q2 2026, its #317 holding.
  • Armistice Capital first reported a position in Creative Medical Technology in Q2 2022 and has held it in 3 quarters since.
  • Armistice Capital's Creative Medical Technology position peaked at $933K in Q2 2022.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.